News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,870 Results
Type
Article (7530)
Company Profile (117)
Press Release (172217)
Multimedia
Podcasts (73)
Webinars (11)
Section
Business (54199)
Career Advice (408)
Deals (9841)
Drug Delivery (34)
Drug Development (32137)
Employer Resources (76)
FDA (2812)
Job Trends (4239)
News (97255)
Policy (6853)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (269)
Accelerated approval (6)
Adcomms (4)
Allergies (47)
Alliances (12401)
ALS (60)
Alzheimer's disease (491)
Antibody-drug conjugate (ADC) (131)
Approvals (2975)
Artificial intelligence (163)
Autoimmune disease (60)
Automation (10)
Bankruptcy (64)
Best Places to Work (3228)
BIOSECURE Act (16)
Biosimilars (105)
Biotechnology (75)
Bladder cancer (39)
Brain cancer (19)
Breast cancer (152)
Cancer (1545)
Cardiovascular disease (100)
Career advice (372)
Career pathing (28)
CAR-T (105)
CDC (12)
Cell therapy (239)
Cervical cancer (7)
Clinical research (28615)
Collaboration (606)
Compensation (637)
Complete response letters (22)
COVID-19 (702)
CRISPR (20)
C-suite (368)
Cystic fibrosis (38)
Data (2290)
Decentralized trials (1)
Denatured (13)
Depression (61)
Diabetes (123)
Diagnostics (657)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (20)
Drug discovery (61)
Drug pricing (58)
Drug shortages (3)
Duchenne muscular dystrophy (67)
Earnings (24510)
Editorial (40)
Employer branding (10)
Employer resources (65)
Events (36175)
Executive appointments (440)
FDA (3843)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (443)
Gene editing (43)
Generative AI (17)
Gene therapy (156)
GLP-1 (327)
Government (837)
Grass and pollen (1)
Guidances (138)
Healthcare (2374)
HIV (22)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (80)
Immuno-oncology (29)
Indications (39)
Infectious disease (769)
Inflammatory bowel disease (66)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (85)
Interviews (79)
IPO (5830)
IRA (18)
Job creations (1035)
Job search strategy (283)
JPM (34)
Kidney cancer (8)
Labor market (74)
Layoffs (177)
Leadership (29)
Legal (925)
Liver cancer (31)
Longevity (3)
Lung cancer (261)
Lymphoma (125)
Machine learning (16)
Management (24)
Manufacturing (310)
MASH (102)
Medical device (480)
Medtech (482)
Mergers & acquisitions (4495)
Metabolic disorders (437)
Multiple sclerosis (69)
NASH (8)
Neurodegenerative disease (89)
Neuropsychiatric disorders (33)
Neuroscience (937)
NextGen: Class of 2026 (1011)
Non-profit (251)
Now hiring (51)
Obesity (203)
Opinion (111)
Ovarian cancer (49)
Pain (56)
Pancreatic cancer (61)
Parkinson's disease (75)
Partnered (4)
Patents (142)
Patient recruitment (187)
Peanut (18)
People (18041)
Pharmaceutical (36)
Pharmacy benefit managers (5)
Phase 1 (8641)
Phase 2 (13137)
Phase 3 (9638)
Pipeline (2002)
Policy (128)
Postmarket research (511)
Preclinical (3264)
Press Release (19)
Prostate cancer (62)
Psychedelics (19)
Radiopharmaceuticals (127)
Rare diseases (280)
Real estate (1219)
Recruiting (32)
Regulatory (6564)
Reports (28)
Research institute (309)
Resumes & cover letters (45)
RNA editing (4)
RSV (26)
Schizophrenia (103)
Series A (73)
Series B (53)
Service/supplier (4)
Sickle cell disease (23)
Special edition (23)
Spinal muscular atrophy (49)
Sponsored (6)
Startups (982)
State (1)
Stomach cancer (2)
Supply chain (24)
Tariffs (46)
The Weekly (59)
Vaccines (249)
Venture capital (48)
Weight loss (92)
Women's health (19)
Worklife (15)
Date
Last 7 days (192)
Last 30 days (743)
Last 365 days (11059)
2026 (1036)
2025 (11154)
2024 (12597)
2023 (14384)
2022 (16291)
2021 (17907)
2020 (15274)
2019 (10056)
2018 (7218)
2017 (8972)
2016 (7369)
2015 (9363)
2014 (7128)
2013 (5128)
2012 (4952)
2011 (4878)
2010 (4829)
Location
Africa (179)
Alabama (21)
Arizona (27)
Arkansas (2)
Asia (14350)
Australia (1582)
California (4278)
Canada (849)
China (711)
Colorado (160)
Connecticut (174)
Delaware (181)
Europe (25950)
Florida (592)
Georgia (129)
Idaho (4)
Illinois (225)
India (22)
Indiana (140)
Iowa (13)
Japan (167)
Kansas (72)
Kentucky (11)
Louisiana (1)
Maine (3)
Maryland (427)
Massachusetts (3355)
Michigan (48)
Minnesota (128)
Mississippi (2)
Missouri (29)
Montana (1)
Nebraska (6)
Nevada (14)
New Hampshire (7)
New Jersey (1372)
New Mexico (7)
New York (1366)
North Carolina (554)
Northern California (2260)
Ohio (120)
Oklahoma (7)
Oregon (13)
Pennsylvania (739)
Puerto Rico (12)
Rhode Island (11)
South America (222)
South Carolina (6)
Southern California (1631)
Tennessee (17)
Texas (453)
United States (14695)
Utah (91)
Virginia (90)
Washington D.C. (24)
Washington State (272)
West Virginia (1)
Wisconsin (19)
179,870 Results for "cue biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cue Biopharma Announces Pricing of $10 Million Public Offering
December 22, 2025
·
5 min read
Press Releases
Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 13, 2025
·
8 min read
Press Releases
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
November 7, 2025
·
9 min read
Press Releases
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
August 14, 2025
·
7 min read
Press Releases
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference
August 22, 2025
·
1 min read
Press Releases
Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates
September 30, 2025
·
8 min read
Press Releases
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 13, 2025
·
8 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 5, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
July 17, 2025
·
7 min read
Press Releases
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
July 1, 2025
·
7 min read
1 of 17,987
Next
